Your browser doesn't support javascript.
loading
Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes.
Lotta, Luca A; Stewart, Isobel D; Sharp, Stephen J; Day, Felix R; Burgess, Stephen; Luan, Jian'an; Bowker, Nicholas; Cai, Lina; Li, Chen; Wittemans, Laura B L; Kerrison, Nicola D; Khaw, Kay-Tee; McCarthy, Mark I; O'Rahilly, Stephen; Scott, Robert A; Savage, David B; Perry, John R B; Langenberg, Claudia; Wareham, Nicholas J.
Afiliación
  • Lotta LA; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Stewart ID; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Sharp SJ; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Day FR; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Burgess S; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Luan J; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Bowker N; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Cai L; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Li C; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Wittemans LBL; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Kerrison ND; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Khaw KT; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • McCarthy MI; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • O'Rahilly S; Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, United Kingdom.
  • Scott RA; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Savage DB; NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom.
  • Perry JRB; Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Langenberg C; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Wareham NJ; Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
JAMA Cardiol ; 3(10): 957-966, 2018 10 01.
Article en En | MEDLINE | ID: mdl-30326043
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Diabetes Mellitus Tipo 2 / Lipoproteína Lipasa / LDL-Colesterol Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Cardiol Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Diabetes Mellitus Tipo 2 / Lipoproteína Lipasa / LDL-Colesterol Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Cardiol Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido